Gross Margin Rose to 8.5% through High-Tech Products Mix and Cost Efficiencies BEIJING, Nov. 13, 2025 -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a Nevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today announces its unaudited financial results for its first fiscal quarter ended September 30, 2025. Additional information will also be set forth in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. First Quarter Fiscal 2026 Highlights
CHONGQING, China, Nov. 13, 2025 -- The 19th China (Chongqing) Senior Citizen Expo and the 1st Western International Conference on High-quality Development of Silver Economy, and the 6th China (Chongqing) Health Industry Expo (hereinafter referred to as the "Senior Citizen Expo") were successfully held at the Chongqing International Expo Center from November 7 to 9, 2025, guided by the China Association of Social Welfare and Senior Service and the China Silver Industry Association, and hosted by the Chongqing Pension Service Association, the China Chamber of International Commerce Ch
SEOUL, South Korea, Nov. 13, 2025 -- LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Material Transfer Agreement (MTA) with a leading global pharmaceutical company for its proprietary blood-brain barrier (BBB) shuttle platform, ExoPN-101. This marks LISCure's fourth MTA, further validating the technological innovation and commercial potential of the ExoPN-101 platform in the global market. ExoPN-101 is a next-generation BBB-penetrating delivery platform
[ 메디채널 김갑성 기자 ] Uniting Global Proton Therapy Leaders to Advance Precision Cancer Treatment HONG KONG, Nov. 13, 2025 -- Hosted by The Li Shu Fan Medical Foundation and HKSH Medical Group (HKSH), and organised by the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO), the 5th Annual Conference of the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO 2025 Conference) was successfully held from 7 to 9 November 2025. Marking the first-ever landmark particle therapy academic conference in Hong Kong, the PTCOG-AO 2025 Conference attracted close to 600 participants from 16
BANGKOK, Nov. 13, 2025 -- MP Group (Thailand) Co., Ltd., a pioneering force in the Thai healthcare ecosystem, was proudly honored with the Corporate Excellence Award at the Asia Pacific Enterprise Awards (APEA) Thailand Chapter, organized by Enterprise Asia. This accolade celebrates the company's remarkable journey, marked by two decades of unwavering commitment to medical innovation, holistic wellness, and empowering the community to "Live An Excellent Life." Founded in 2001, MP Group began as a distributor of medical diagnostic devices and has since evolved into a comprehen
BANGKOK, Nov. 13, 2025 -- The journey of Mr. Sara Lamsam, CEO of Muang Thai Life Assurance (MTL), is a testament to the power of fusing strategic leadership with digital innovation. His success has been recognized with the Master Entrepreneur Award at the Asia Pacific Enterprise Awards (APEA) Thailand organised by Enterprise Asia, while his transformative work at the company earned MTL the Corporate Excellence Award. With over 32 years of experience and a strong belief in continuous self-development, Sara has spent his career modernizing the insurance industry. He spearheaded the cruci
Report highlights emerging biotech innovators advancing new therapies, equity and investment across reproductive, chronic and mental health LONDON, Nov. 13, 2025 -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its latest Companies to Watch report, Rediscovering Women's Health, highlighting seven companies driving innovation across reproductive care, chronic disease and mental health. Drawing on proprietary data, expert analysis and insights into therapeutic impact, financing activity and R&D momentum, the report showca
CHIANG MAI, Thailand, Nov. 13, 2025 -- A major step forward in regional collaboration for cancer care was announced today with the launch of Project ACTIVE 2.0 (Advancing Cervical Cancer Treatment & Patient Recovery Across Southeast Asia), a multi-country initiative that aims to strengthen radiation oncology services and improve outcomes for cervical cancer across Southeast Asia. This effort is backed by the German Federal Ministry of Economic Cooperation and Development - BMZ, DEG Impulse, the Embassy of the Federal Republic of Germany in Bangkok, Elekta, and the Federatio
XI'AN, China, Nov. 13, 2025 -- Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group and an innovator in veterinary point-of-care testing (POCT) solutions, presents the enhanced FOCUS PEGASUS MF200 Automatic Multifunctional Veterinary Analyzer — a next-generation system that redefines efficiency, reliability, and accessibility in veterinary diagnostics. The MF200 integrates Biochemistry, Electrolytes, Coagulation, and Immunofluorescence testing into one compact analyzer — delivering smart point-of-care diagnostics that meet the demands of modern veterinary practice
FC Barcelona Striker Partners with Most Clinically Researched Ashwagandha Brand, KSM-66 LOS ANGELES, Nov. 13, 2025 -- KSM-66®, one of the world's largest natural product ingredient brands and best-selling ashwagandha extract, today announced Robert Lewandowski as its global brand ambassador. The FC Barcelona striker and Poland captain will represent the brand worldwide across all markets where KSM-66 operates. The partnership pairs Lewandowski's two-decade career at football's elite level with KSM-66 Ashwagandha's commitment to 4000 year old Ayurvedic traditi